heidi merethe hoff naken sorted by
relevance

Admin20.09.2021

Heidi merethe hoff naken

National cooperating centers and other cooperating partners Hospitals and centers from all parts of Norway and all four health regions will participate in the BIOSTOP Study.
5707
Admin11.09.2021

stalheimsklevia

To assess if discontinuing anti-TNF treatment in ulcerative colitis UC patients in sustained clinical remission, with the option to restart treatment in the case of relapse, is non-inferior to continued anti-TNF therapy.
66010
Admin16.08.2021

stalheimsklevia

continuing anti-TNF in UC patients in remiss.
1408
Admin30.06.2021

stalheimsklevia

About the project In the BIOSTOP Study ulcerative colitis patients in remission after at least one year anti-TNF maintenance therapy will be included.
409
Admin07.07.2021

BIOSTOP

Pris kr 350 spar kr 49.
3703
Admin20.08.2021

Frimurernes hemmeligheter bok

A prospective, open randomized, parallel-Group study to evaluate the outcome of discontinuing vs.
7602
Admin01.09.2021

Frimurernes hemmeligheter bok

Roger Karsten Aase ble tatt opp i Den Norske Frimurerlosjen i 1993.
2704
Admin11.09.2021

stalheimsklevia

Patients will be openly randomized to either discontinuing anti-TNF intervention group or continuing anti-TNF control group for 2 years.
8006
Admin25.08.2021

Heidi merethe hoff naken

All principal investigators are experienced in anti-TNF and other immunosuppressive treatment in inflammatory bowel disease.
2107
Admin03.09.2021

Heidi merethe hoff naken

If clinical remission is confirmed by symptom score and faecal calprotectin, a full ileocolonoscopy is performed.
4601
Admin26.08.2021

Heidi merethe hoff naken

The electronic case report file is set up and maintained by Cecilie Moe at Unit for Applied Clinical Research AKF at Oslo University Hospital.
Admin08.09.2021

BIOSTOP

Foundation for the randomized part of the study 2017 — 2021 is granted by the Norwegian Research Council and MR Hospital Trust, and also the last 2 years will be partially financed by MR Hospital Trust•.
5502